267 related articles for article (PubMed ID: 15482639)
1. An ocular drug delivery system containing zinc diethyldithiocarbamate and HPbetaCD inclusion complex--corneal permeability, anti-cataract effects and mechanism studies.
Wang S; Li D; Ito Y; Liu X; Zhang J; Wu C
J Pharm Pharmacol; 2004 Oct; 56(10):1251-7. PubMed ID: 15482639
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
3. Delay in ICR/f rat lens opacification by the instillation of eye drops containing disulfiram and hydroxypropyl-beta-cyclodextrin inclusion complex.
Nagai N; Takeda M; Ito Y; Takeuchi N; Kamei A
Biol Pharm Bull; 2007 Aug; 30(8):1529-34. PubMed ID: 17666815
[TBL] [Abstract][Full Text] [Related]
4. In vitro cell culture model for anti-cataract drug penetration studies.
Jiang TY; Wang SL; Liu Y; Nie SF; Ito Y; Nagai N; Wu CF
Pharmazie; 2007 Oct; 62(10):767-72. PubMed ID: 18236782
[TBL] [Abstract][Full Text] [Related]
5. Diethyldithiocarbamate inhibits iNOS expression in human lens epithelial cells stimulated by IFN-gamma and LPS.
Li DX; Wang SL; Ito Y; Zhang JH; Wu CF
Acta Pharmacol Sin; 2005 Mar; 26(3):359-63. PubMed ID: 15715934
[TBL] [Abstract][Full Text] [Related]
6. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans.
Kristinsson JK; Fridriksdóttir H; Thórisdóttir S; Sigurdardóttir AM; Stefánsson E; Loftsson T
Invest Ophthalmol Vis Sci; 1996 May; 37(6):1199-203. PubMed ID: 8631635
[TBL] [Abstract][Full Text] [Related]
8. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
Nagai N; Yoshioka C; Mano Y; Tnabe W; Ito Y; Okamoto N; Shimomura Y
Exp Eye Res; 2015 Mar; 132():115-23. PubMed ID: 25633346
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
10. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.
Nogueiras-Nieto L; Sobarzo-Sánchez E; Gómez-Amoza JL; Otero-Espinar FJ
Eur J Pharm Biopharm; 2012 Apr; 80(3):585-95. PubMed ID: 22182528
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
12. Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea.
Okamoto N; Ito Y; Nagai N; Murao T; Takiguchi Y; Kurimoto T; Mimura O
J Oleo Sci; 2010; 59(8):423-30. PubMed ID: 20625234
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir.
Tirucherai GS; Mitra AK
AAPS PharmSciTech; 2003; 4(3):E45. PubMed ID: 14621977
[TBL] [Abstract][Full Text] [Related]
15. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
Tewes F; Brillault J; Couet W; Olivier JC
J Control Release; 2008 Jul; 129(2):93-9. PubMed ID: 18514353
[TBL] [Abstract][Full Text] [Related]
16. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
17. The novel application of tertiary butyl alcohol in the preparation of hydrophobic drug-HPbetaCD complex.
Wang Z; Deng Y; Zhang X
J Pharm Pharmacol; 2006 Mar; 58(3):409-14. PubMed ID: 16536910
[TBL] [Abstract][Full Text] [Related]
18. Improving the solubility of vorinostat using cyclodextrin inclusion complexes: The physicochemical characteristics, corneal permeability and ocular pharmacokinetics of the drug after topical application.
Yang J; Ma Y; Luo Q; Liang Z; Lu P; Song F; Zhang Z; Zhou T; Zhang J
Eur J Pharm Sci; 2022 Jan; 168():106078. PubMed ID: 34838620
[TBL] [Abstract][Full Text] [Related]
19. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
Nagai N; Ito Y; Okamoto N; Shimomura Y
Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
[TBL] [Abstract][Full Text] [Related]
20. Formulation of indomethacin eye drops via complexation with cyclodextrins.
Halim Mohamed MA; Mahmoud AA
Curr Eye Res; 2011 Mar; 36(3):208-16. PubMed ID: 21275515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
